Navigation Links
SemBioSys to present new data at American Diabetes Association,annual meeting

"believe", "may", "plan", "will", "estimate", "continue", "anticipate", "intend", "expect" and other similar expressions which constitute "forward-looking information" within the meaning of applicable Canadian securities laws. Forward-looking statements reflect the Company's current expectation and assumptions, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process and other risks detailed from time-to-time in the Company's ongoing filings with the Canadian securities regulatory authorities which filings can be found at www.sedar.com. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements either as a result of new information, future events or otherwise, except as required by applicable Canadian securities laws.

CONTACT: SemBioSys Genetics Inc., Mr. Andrew Baum, President and ChiefExecutive Officer, Phone: (403) 717-8767, Fax: (403) 250-3886, E-mail:, Internet: www.sembiosys.com; Investor Relations, RossMarshall, The Equicom Group Inc., Phone: (416) 815-0700 (Ext. 238), Fax:(416) 815-0080, E-mail: bauma@sembiosys.com rmarshall@equicomgroup.com

Ticker Symbol: (Toronto:SBS.)

Terms and conditions of use apply
Copyr
'"/>




Page: 1 2 3

Related medicine technology :

1. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Pharmexa A/S (DK) - Pharmexa presents data from influenza program
4. Active Biotech presents new pre-clinical data for the 57-57 project at the 8th World Congress on Inflammation
5. CYT003-QbG10 to treat allergy to be presented at the Congress of the European Academy of Allergology and Clinical Immunology (EAACI), June 9-13, 2007
6. Data to be presented at AAN Meeting -Study results of drug candidate for MS
7. Amsterdam Molecular Therapeutics BV to present preclinical proof-of-concept data on its gene therapy AMT-020 to treat acute intermittent porphyria
8. Santaris Pharma presents positive preclinical data on SPC2996 at the American Association for Cancer Research
9. Data supporting three Antisoma programmes presented at AACR
10. West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak
11. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
Post Your Comments:
(Date:5/9/2008)... Agency biologists will play key role in nationa...ildlife Conservation Education Specialist, Pennsy...ny the following article are available from the,Ga...us ) by clicking on "Release,#049-08.", HARRISB...nsylvania Game,Commission has found itself on a ne...
(Date:5/9/2008)... TAMPA, Fla., May 9 /PRNewswire-USNewswire/ -- Os...ting condition that affects almost 50,million peop...tion of,cartilage in bone joints. The novel invest...acting oral analgesic, provided significant relief... those treated with,placebo, and with fewer gastro...
(Date:5/9/2008)... Novel Pain Medicine Studied in Patients Followi...re-USNewswire/ -- Many foot-surgery,patients exper...val of a,bunion, one of the most common foot surge...ol provided significant relief for patients who ha...cebo. Treatment with tapentadol,also resulted in p...
(Date:5/9/2008)... SAN DIEGO, May 9 /- Arde...cused on the discovery and development of,small- m...cer and,inflammatory diseases, including gout, tod...Senior Vice President, Finance and Operations and ... will resign from our board of,directors shortly t...
Breaking Medicine Technology:White Nose Syndrome: Is Pennsylvania Next? 2White Nose Syndrome: Is Pennsylvania Next? 3White Nose Syndrome: Is Pennsylvania Next? 4White Nose Syndrome: Is Pennsylvania Next? 5White Nose Syndrome: Is Pennsylvania Next? 6Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 2Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 3Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 4Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 5New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 3New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 4New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 5Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 2Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 3Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 4Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 5Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results 6January American Naturalist highlights 9100 1January American Naturalist highlights 9100 2January American Naturalist highlights 9100 3January American Naturalist highlights 9100 4January American Naturalist highlights 9100 5January American Naturalist highlights 9100 6January American Naturalist highlights 9100 7January American Naturalist highlights 9100 8January American Naturalist highlights 9100 9January American Naturalist highlights 9100 10January American Naturalist highlights 9100 11January American Naturalist highlights 9100 12January American Naturalist highlights 9100 13Treating Childhood Pneumonia at Home Could Save Lives in Developing Countries 9098 1Treating Childhood Pneumonia at Home Could Save Lives in Developing Countries 9098 2Lilly Sets Date and Conference Call for Fourth Quarter and Full Year 2007 Financial Results Announcement 9096 1RxElite Registration Statement Suspended 9094 1RxElite Registration Statement Suspended 9094 2
...Jun-2007 / Karo Bio (STO:KARO) successful,KB2115 P...k proof,of concept phase II study with KB2115 in p...mpleted. KB2115 is efficacious in LDL,lowering and...reflecting effects on heart, bone, muscle and thyr...s a key regulator of,metabolic pathways and holds ...
... Congress of the European Hematology,Association, ... Favrille,Inc. , a biopharmaceutical company deve...r the treatment of cancer, announced,interim data ...nts,with indolent B-cell non-Hodgkin,s lymphoma (N... European Hematology Association in,Vienna on Satu...
Other Medicine Technology:Karo Bio Announces Sucessfule Phase II Results of KB2115 2Karo Bio Announces Sucessfule Phase II Results of KB2115 3Favrille Announces Data From Phase 2 Clinical Trial of FavId for,Indolent B-Cell Non-Hodgkin's Lymphoma in Europe 2Favrille Announces Data From Phase 2 Clinical Trial of FavId for,Indolent B-Cell Non-Hodgkin's Lymphoma in Europe 3
(Date:5/12/2008)... Reports Record Quarterly Sales of over $25 ...rstCall/ -- Medifast, Inc.,(NYSE: MED ) announced...iod,ended March 31, 2008., Financial highlights...5%;, -- Gross margins increased to 75.8% vs. 74.8...Life experienced sales increase of 63% year-ov...
(Date:5/12/2008)...use Bill Gives FDA Regulatory Authority Over Tobac...- Esperanza, the largest,Hispanic faith-based orga...port of H.R. 1108, "The Family Smoking Prevention ...A regulatory authority over tobacco products., ...slation this year.,H.R. 1108 has broad bi-partisan...
(Date:5/11/2008)...VADA CITY, Calif., May 11 /PRNewswire/ -- The Myan... ) is a coalition of private American and,Myanmar ...directly to the,victims bypassing bureaucratic bar...and a myriad of supplies are being distributed., ...American and Myanmar,citizens with headquarters in...
(Date:5/11/2008)...l Three Crew Members were Fatally Injured; No Pati...tCall/ -- Air Methods Corporation,(Nasdaq: AIRM )...e,helicopters serving the University of Wisconsin ...d Saturday night around 10:30 p.m. CST after,deliv...hysician, and flight,nurse received fatal injuries...
Breaking Medicine News(10 mins):Health News:Medifast Announces First Quarter 2008 Financial Results 2Health News:Medifast Announces First Quarter 2008 Financial Results 3Health News:Medifast Announces First Quarter 2008 Financial Results 4Health News:Medifast Announces First Quarter 2008 Financial Results 5Health News:Medifast Announces First Quarter 2008 Financial Results 6Health News:Medifast Announces First Quarter 2008 Financial Results 7Health News:Medifast Announces First Quarter 2008 Financial Results 8
...les by declaring that some recent imports of raisi...nd destroyed them . That was apparently in retalia...f a variety of products exported by China. But th... shortlived. Now Chinese investigators themselves ...
...n AIDS patient infect the injured with HIV? No, it...ient quantity for you to get infected . That's ano...ected with HIV from a barber's razor. Is it true m...s? Myth again! Most women infected with HIV are ho...
...e you short-tempered: it can also stress your hear...d death, according to a study released Wednesday ....g-term sleep loss have been well-documented, rangi...nd-eye coordination to poor mood. But the study by...
...lothes or wash dishes or even walk up to meet a co...f fighting diabetes and heart disease . A study o... they spent doing low-intensity activities as sim... phone rather than sitting the lower their blood ...
Other Medicine News:Health News:China Admits Fake Blood Protein Used in Drips 2Health News:Armed Forces Enroll Wives in Fighting HIV/AIDS 2Health News:Insufficient Sleep Increases Risk of Cardiovascular Disease: Study 2Health News:Iron Clothes to Lower Blood Sugar Levels 2
The Portex® ULTRAperc® Percutaneous Dilation Tracheostomy Kits allow the percutaneous insertion of a tracheostomy tube using the widely accepted Seldinger technique by means of a single-stage
Self-contained kits provide convenience and cost control. , ,Our full range of tracheostomy care trays offer a variety of wound dressing components for the effective care and management of the trach
Disposable tracheostomy care tray.
Disposable tracheostomy care tray.
Medicine Products: